Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;51(10):3169-3173.
doi: 10.1161/STROKEAHA.120.030486. Epub 2020 Sep 21.

Blowing up Neural Repair for Stroke Recovery: Preclinical and Clinical Trial Considerations

Nick S Ward  1 , S Thomas Carmichael  2
Affiliations
Review

Blowing up Neural Repair for Stroke Recovery: Preclinical and Clinical Trial Considerations

Nick S Ward et al. Stroke. 2020 Oct.

Abstract

The repair and recovery of the brain after stroke is a field that is emerging in its preclinical science and clinical trials. However, recent large, multicenter clinical trials have been negative, and conflicting results emerge on biological targets in preclinical studies. The coalescence of negative clinical translation and confusion in preclinical studies raises the suggestion that perhaps the field of stroke recovery faces a fate similar to stroke neuroprotection, with interesting science ultimately proving difficult to translate to the clinic. This review highlights improvements in 4 areas of the stroke neural repair field that should reorient the field toward successful clinical translation: improvements in rodent genetic models of stroke recovery, consideration of the biological target in stroke recovery, stratification in clinical trials, and the use of appropriate clinical trial end points.

Keywords: confusion; mice, knockout; neurological rehabilitation; pyramidal tracts; rodentia.

PubMed Disclaimer

References

    1. Gladstone DJ, Black SE, Hakim AM, Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke, 2002;33:2123–2136. - PubMed
    1. FOCUS Trial Collaboration. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet. 2019;393:265–274. - PMC - PubMed
    1. Affinity Trial Collaboration. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2020;19:651–660. - PubMed
    1. EFFECTS Trial Collaboration. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2020;19:661–669. - PubMed
    1. Chabriat H, Bassetti CL, Marx U, Audoli-Inthavong M-L, Sors A, Lambert E, Wattez M, Hermann DM, RESTORE BRAIN study investigators. Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2020;19:226–233. - PubMed

Publication types